Sign Up Today and Learn More About Tilray Stock
Invest in or calculate the value of your shares in Tilray or other pre-IPO companies through EquityZen's platform.
Tilray Stock
Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies, and governments.
About Tilray Stock
Founded
2013
Total Funding
60.0M
Industries
Software, Artificial Intelligence, Data and Analytics
Tilray provides pharmaceutical-grade cannabis products to patients, researchers, pharmacies and governments. Tilray cultivates and delivers the benefits of medical cannabis safely and reliably. Healthcare practitioners and patients expect and deserve only the best service and products. Accordingly, Tilray provides expedited delivery, prompt follow-up, and consistent quality of each strain they harvest.
Tilray Press Mentions
Stay in the know about the latest news on Tilray
Tilray Seeks $100 Million IPO In US Filing
Seeking Alpha • Jun 27, 2018
Canada: Tilray files for US float
International Financing Review • Jun 25, 2018
Canadian cannabis company cultivates IPO
PitchBook News & Analysis • Jun 22, 2018
Tilray files for IPO, after Canada legalizes marijuana
Axios • Jun 21, 2018
Tilray® Launches New High-CBD Cannabis Oil for Patients in Need
• May 22, 2018
Tilray Management
Leadership team at Tilray
Director
Catherine Jacobson
Founder
Brendan Kennedy
Join now and verify your accreditation status to gain access to:
- Tilray Current Valuation
- Tilray Stock Price
- Tilray Management
- Available deals in Tilray and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Tilray Cap Table and Funding History by Share Class and Liquidity Preferences
- Tilray Revenue and Financials
- Tilray Highlights
- Tilray Business Model
- Tilray Risk Factors
- Tilray Research Report from SACRA Research
Trading Tilray Stock
How to invest in Tilray stock?
Accredited investors can buy pre-IPO stock in companies like Tilray through EquityZen funds. These investments are made available by existing Tilray shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Tilray stock?
Shareholders can sell their Tilray stock through EquityZen's private company marketplace. EquityZen's network includes over 380K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 47K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."